title: [A patient with recurrent ovarian clear cell adenocarcinoma and chronic kidney disease exhibited complete response to paclitaxel plus carboplatin].
abstract: A 41-year-old woman receiving hemodialysis 3 times a week for chronic kidney disease caused by interstitial nephritis was referred to our hospital because of a pelvic mass and subsequently underwent primary surgery. The patient was diagnosed with FIGO stage Ic (b) clear cell adenocarcinoma. She did not receive postoperative chemotherapy. However, 9 months after surgery, ascites and a pelvic mass developed, on the basis of which recurrence was confirmed. She received combination chemotherapy with paclitaxel plus carboplatin (TC). Paclitaxel was administered at 175 mg/m2, and the carboplatin dosage was calculated by the Calvert formula. The glomerular filtration rate was considered to be 0, and the target area under the plasma concentration versus time curve was 5. Hemodialysis was performed 24 hours after the infusion of carboplatin. After 6 courses of combination chemotherapy, complete response was confirmed by computed tomography. The patient developed grade 3 neutropenia, grade 1 sensory neuropathy , and grade 2 alopecia, but the other adverse events were mild. In conclusion, TC combination chemotherapy was well tolerated and generated a good response in a patient with recurrent ovarian clear cell adenocarcinoma who was receiving hemodialysis for chronic kidney disease.
authors.affiliation: Dept. of Obstetrics and Gynecology, Kurume University School of Medicine.
authors.forename: Megumi
authors.initials: M
authors.lastname: Muto
authors.forename: Shin
authors.initials: S
authors.lastname: Nishio
authors.forename: Shuji
authors.initials: S
authors.lastname: Takemoto
authors.forename: Shunichiro
authors.initials: S
authors.lastname: Ota
authors.forename: Gonosuke
authors.initials: G
authors.lastname: Sonoda
authors.forename: Kimio
authors.initials: K
authors.lastname: Ushijima
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Kamura
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D012008:Recurrence; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy
chemical_list: D016190:Carboplatin; D017239:Paclitaxel